Haefeli WE - Search Results

1

[Clinically relevant adverse drug interactions].

Martin-Facklam M, Haefeli WE. Martin-Facklam M, et al. Among authors: haefeli we. Ther Umsch. 2000 Sep;57(9):579-83. doi: 10.1024/0040-5930.57.9.579. Ther Umsch. 2000. PMID: 11036439 Review. German.

2

Dose-dependent increase of saquinavir bioavailability by the pharmaceutic aid cremophor EL.

Martin-Facklam M, Burhenne J, Ding R, Fricker R, Mikus G, Walter-Sack I, Haefeli WE. Martin-Facklam M, et al. Among authors: haefeli we. Br J Clin Pharmacol. 2002 Jun;53(6):576-81. doi: 10.1046/j.1365-2125.2002.01595.x. Br J Clin Pharmacol. 2002. PMID: 12047481 Free PMC article. Clinical Trial.

3

A drug database model as a central element for computer-supported dose adjustment within a CPOE system.

Martin P, Haefeli WE, Martin-Facklam M. Martin P, et al. Among authors: haefeli we. J Am Med Inform Assoc. 2004 Sep-Oct;11(5):427-32. doi: 10.1197/jamia.M1296. Epub 2004 Jun 7. J Am Med Inform Assoc. 2004. PMID: 15187062 Free PMC article.

4

Dose individualisation in patients with renal insufficiency: does drug labelling support optimal management?

Martin-Facklam M, Rengelshausen J, Tayrouz Y, Ketabi-Kiyanvash N, Lindenmaier H, Schneider V, Bergk V, Haefeli WE. Martin-Facklam M, et al. Among authors: haefeli we. Eur J Clin Pharmacol. 2005 Jan;60(11):807-11. doi: 10.1007/s00228-004-0852-y. Epub 2004 Dec 14. Eur J Clin Pharmacol. 2005. PMID: 15599503

5

Information deficits in the summary of product characteristics preclude an optimal management of drug interactions: a comparison with evidence from the literature.

Bergk V, Haefeli WE, Gasse C, Brenner H, Martin-Facklam M. Bergk V, et al. Among authors: haefeli we. Eur J Clin Pharmacol. 2005 Jul;61(5-6):327-35. doi: 10.1007/s00228-005-0943-4. Epub 2005 Jun 28. Eur J Clin Pharmacol. 2005. PMID: 15983822

6

[Drug interactions with the cytochrome P-450 system].

Martin-Facklam M, Drewe J, Haefeli WE. Martin-Facklam M, et al. Among authors: haefeli we. Dtsch Med Wochenschr. 2000 Jan 21;125(3):63-7. doi: 10.1055/s-2007-1023908. Dtsch Med Wochenschr. 2000. PMID: 10682001 Review. German. No abstract available.

7

Quality markers of drug information on the Internet: an evaluation of sites about St. John's wort.

Martin-Facklam M, Kostrzewa M, Schubert F, Gasse C, Haefeli WE. Martin-Facklam M, et al. Among authors: haefeli we. Am J Med. 2002 Dec 15;113(9):740-5. doi: 10.1016/s0002-9343(02)01256-1. Am J Med. 2002. PMID: 12517364

8

Quality of drug information on the World Wide Web and strategies to improve pages with poor information quality. An intervention study on pages about sildenafil.

Martin-Facklam M, Kostrzewa M, Martin P, Haefeli WE. Martin-Facklam M, et al. Among authors: haefeli we. Br J Clin Pharmacol. 2004 Jan;57(1):80-5. doi: 10.1046/j.1365-2125.2003.01954.x. Br J Clin Pharmacol. 2004. PMID: 14678344 Free PMC article. Clinical Trial.

9

Oral contraception does not alter single dose saquinavir pharmacokinetics in women.

Fröhlich M, Burhenne J, Martin-Facklam M, Weiss J, von Wolff M, Strowitzki T, Walter-Sack I, Haefeli WE. Fröhlich M, et al. Among authors: haefeli we. Br J Clin Pharmacol. 2004 Mar;57(3):244-52. doi: 10.1111/j.1365-2125.2003.01983.x. Br J Clin Pharmacol. 2004. PMID: 14998420 Free PMC article. Clinical Trial.

10

High prevalence of unknown co-medication in hospitalised patients.

Rieger K, Scholer A, Arnet I, Peters FT, Maurer HH, Walter-Sack I, Haefeli WE, Martin-Facklam M. Rieger K, et al. Among authors: haefeli we. Eur J Clin Pharmacol. 2004 Jul;60(5):363-8. doi: 10.1007/s00228-004-0784-6. Epub 2004 Jun 10. Eur J Clin Pharmacol. 2004. PMID: 15197522

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

588 results

Search Page

Filters